In the United States, immunocompromised people were allowed to receive a third dose of Moderna or Pfizer vaccine. In the United States, tens of thousands of people will receive an additional dose.
The United States Food and Drug Administration (FDA) has updated its authorization for the emergency use of COVID-19 vaccines. The agency allowed immunocompromised people to receive a third dose of the vaccine at least 28 days after the two doses were given to further enhance protection. The FDA said the change will affect tens of thousands of people in the country.
“The country has entered the next wave of the COVID-19 pandemic, and the FDA is especially aware that people with weakened immune systems are at risk of serious illness. After carefully reviewing the available data, the FDA has determined that a third dose of Pfizer-BioNTech or Moderna vaccines could benefit a small vulnerable group, ”said Acting FDA Commissioner Janet Woodcock.
“As we stated earlier, people who are fully vaccinated are sufficiently protected and do not need an additional dose of COVID-19 vaccine. The FDA is actively involved in a scientifically based, rigorous process with our federal partners to consider the need for an additional dose in the future, ”the FDA added.
The FDA is expected to approve the third dose of Moderna and Pfizer / BioNTech mRNA vaccines. They will get permission for the third dose by updating the emergency use documents.
Johnson & Johnson’s COVID-19 single-dose vaccine has been removed from updates. According to Politico sources, this is due to the fact that very few people with weakened immunity have previously received the Johnson & Johnson vaccine.